2. Academic Validation
  3. Lactic Acid Fermentation Is Required for NLRP3 Inflammasome Activation

Lactic Acid Fermentation Is Required for NLRP3 Inflammasome Activation

  • Front Immunol. 2021 Mar 29;12:630380. doi: 10.3389/fimmu.2021.630380.
Hsin-Chung Lin 1 2,  Yu-Jen Chen 3 4 5,  Yau-Huei Wei 6,  Hsin-An Lin 7,  Chien-Chou Chen 7,  Tze-Fan Liu 8,  Yi-Lin Hsieh 8,  Kuo-Yang Huang 9,  Kuan-Hung Lin 10,  Hsueh-Hsiao Wang 8,  Lih-Chyang Chen 8
Affiliations

Affiliations

  • 1 Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.
  • 2 Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, Taipei, Taiwan.
  • 3 Department of Radiation Oncology, MacKay Memorial Hospital, New Taipei City, Taiwan.
  • 4 Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan.
  • 5 Department of Nursing, MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan.
  • 6 Center for Mitochondrial Medicine and Free Radical Research, Changhua Christian Hospital, Changhua, Taiwan.
  • 7 Department of Medicine, Tri-Service General Hospital SongShan Branch, Taipei, Taiwan.
  • 8 Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
  • 9 Graduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, Taiwan.
  • 10 Institute of Biomedical Sciences, MacKay Medical College, New Taipei City, Taiwan.
PMID: 33854503 DOI: 10.3389/fimmu.2021.630380
Abstract

Activation of the NOD-like Receptor 3 (NLRP3) inflammasome is important for activation of innate immune responses, but improper and excessive activation can cause inflammatory disease. We previously showed that glycolysis, a metabolic pathway that converts glucose into pyruvate, is essential for NLRP3 inflammasome activation in macrophages. Here, we investigated the role of metabolic pathways downstream glycolysis - lactic acid fermentation and pyruvate oxidation-in activation of the NLRP3 inflammasome. Using pharmacological or genetic approaches, we show that decreasing lactic acid fermentation by inhibiting Lactate Dehydrogenase reduced Caspase-1 activation and IL-1β maturation in response to various NLRP3 inflammasome agonists such as nigericin, ATP, monosodium urate (MSU) crystals, or alum, indicating that lactic acid fermentation is required for NLRP3 inflammasome activation. Inhibition of Lactate Dehydrogenase with GSK2837808A reduced lactate production and activity of the NLRP3 inflammasome regulator, phosphorylated protein kinase R (PKR), but did not reduce the common trigger of NLRP3 inflammasome, potassium efflux, or Reactive Oxygen Species (ROS) production. By contrast, decreasing the activity of pyruvate oxidation by depletion of either mitochondrial pyruvate carrier 2 (MPC2) or pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) enhanced NLRP3 inflammasome activation, suggesting that inhibition of mitochondrial pyruvate transport enhanced lactic acid fermentation. Moreover, treatment with GSK2837808A reduced MSU-mediated peritonitis in mice, a disease model used for studying the consequences of NLRP3 inflammasome activation. Our results suggest that lactic acid fermentation is important for NLRP3 inflammasome activation, while pyruvate oxidation is not. Thus, reprograming pyruvate metabolism in mitochondria and in the cytoplasm should be considered as a novel strategy for the treatment of NLRP3 inflammasome-associated diseases.

Keywords

NLRP3 inflammasome; glycolysis; inflammation; lactic acid fermentation; pyruvate oxidation.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z